Shield — Clinical data readout
2031
The SOLAR study will continue patient enrollment into 2026, and we aim to conclude the SOLAR study by 2031.Source filing
GH biotech catalysts & pipeline
GUARDANT HEALTH INC · Data as of 2026-10-25
catalyst calendar
/